Q1 2015 13F Holders as of 31 Mar 2015
-
Type / Class
-
Equity / Common Stock, $0.0001 Par Value Per Share
-
Shares outstanding
-
107,800,271
-
Total 13F shares
-
16,955,478
-
Share change
-
+4,675,845
-
Total reported value
-
$404,896,238
-
Price per share
-
$23.88
-
Number of holders
-
74
-
Value change
-
+$111,856,653
-
Number of buys
-
53
-
Number of sells
-
14
Institutional Holders of Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI) as of Q1 2015
As of 31 Mar 2015,
Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,955,478 shares.
The largest 10 holders included
FMR LLC, BlackRock Advisors LLC, WASATCH ADVISORS INC, BlackRock Fund Advisors, Visium Asset Management, LP, ADAGE CAPITAL PARTNERS GP LLC, Redmile Group, LLC, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., and FRANKLIN RESOURCES INC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.